Obesity-related glomerulopathy: body mass index and proteinuria. - Wikidata - wikimedia - TriplyDB

Obesity-related glomerulopathy: body mass index and proteinuria.

Obesity-related glomerulopathy: body mass index and proteinuria.

http://www.wikidata.org/entity/Q34075430

about

Prevalence of obesity by occupation among US workers: the National Health Interview Survey 2004-2011 Mid-adulthood risk factor profiles for CKD The relationship between obesity and diabetic nephropathy in China.Metabolically healthy obesity and risk of incident CKD.Cardiovascular and renal effects of weight reduction in obesity and the metabolic syndrome.Effects of Weight Loss Speed on Kidney Function Differ Depending on Body Mass Index in Nondiabetic Healthy People: A Prospective Cohort.The Combined Influence of Psychological Factors on Biomarkers of Renal Functioning in African Americans.Consequences of morbid obesity on the kidney. Where are we going?Obesity, hypertension, and chronic kidney disease.Potential Association between Breakfast Skipping and Concomitant Late-Night-Dinner Eating with Metabolic Syndrome and Proteinuria in the Japanese Population.The role of obesity in kidney disease: recent findings and potential mechanisms.Off the beaten renin-angiotensin-aldosterone system pathway: new perspectives on antiproteinuric therapy.The biological consequence of obesity on the kidney.Effects of weight loss on renal function in obese CKD patients: a systematic review.Long-Term Normal Renal Function after Drastic Weight Reduction in Patients with Obesity-Related Glomerulopathy.Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity.

P2860

Q23914117-00634E71-B51B-41D2-81B9-3CFB86F3E1F7 Q34427602-24C8D951-9757-4F23-B940-DDBDB148D2D2 Q34632532-B254AC48-08C5-4BAE-BA66-1416FF148F33 Q35278585-100C374B-0818-4F8C-95F9-021D302A9642 Q35592620-87D53185-B5B4-4222-8914-7A7C7F88CDAC Q35849937-4FD0AC54-7E5B-49EC-9952-372B6455D87E Q36036041-8F5A1283-4F46-4FC8-8078-AAA87F6F8D10 Q37511029-5AAAEC0D-6842-4BAF-AA3A-A61AD8F6EBCE Q37601245-707A0C93-0078-46C7-9A34-5BD38C812FEA Q37699925-696BCA9A-A51C-4A06-B51F-0A4A053774F4 Q37872237-FADB5662-FF48-4D1D-A278-81588E563F50 Q37904098-5EAF06E9-6F6C-433F-8535-A8F49931EB39 Q38112518-62590B39-44F2-406E-9A35-FAA549003737 Q38149111-29C60FB1-8792-43D3-ABDD-16EDD2821FFB Q47108672-9FAAFD0D-AA00-4026-8E75-0A5B1FD17581 Q48196703-59363C01-8268-4AD7-AF89-B3373CA64D3C

P2860

Obesity-related glomerulopathy: body mass index and proteinuria.

http://www.wikidata.org/entity/Q34075430

description

2010 nî lūn-bûn

@nan

2010 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Obesity-related glomerulopathy: body mass index and proteinuria.

@ast

Obesity-related glomerulopathy: body mass index and proteinuria.

@en

Obesity-related glomerulopathy: body mass index and proteinuria.

@nl

type

label

Obesity-related glomerulopathy: body mass index and proteinuria.

@ast

Obesity-related glomerulopathy: body mass index and proteinuria.

@en

Obesity-related glomerulopathy: body mass index and proteinuria.

@nl

prefLabel

Obesity-related glomerulopathy: body mass index and proteinuria.

@ast

Obesity-related glomerulopathy: body mass index and proteinuria.

@en

Obesity-related glomerulopathy: body mass index and proteinuria.

@nl

P1433

Q34075430-6EA71970-A8D8-498C-9CF4-69F82B50340C

P1476

Q34075430-BC96BE46-8216-4BE1-AEAD-94B10FAC4435

P2093

Q34075430-05B42DB0-5BFB-4690-970A-3F4A0B27F28D

Q34075430-2B1AC071-DCF6-4BD7-8CA1-0BF8C15CC8AD

Q34075430-586B3BE7-2D3C-4761-8C8E-234727BFD4F1

Q34075430-734D27AC-3202-465C-BA95-4B44B591CE80

Q34075430-ACF4E459-70B7-43E1-97E9-5FC52C495980

P2860

Q34075430-034CE0EE-8537-4C53-B32E-3087D797C299

Q34075430-1574C6DB-75C0-4FCC-A830-4C537854E40E

Q34075430-178C683B-2E68-4BC3-871D-90A60C17A9D5

Q34075430-204340FB-DE8C-4475-9446-8CEFC80F6FE1

Q34075430-37D691A2-D994-489C-ABCC-342867F167B8

Q34075430-5B06C3F6-CCC5-429F-84B5-34101C796650

Q34075430-72492F01-71D6-4B3E-AE2C-6CAE1BB46AC5

Q34075430-7AD6B135-40B8-489B-AB1E-5C04265ED353

Q34075430-7EA3883D-D544-462F-8897-397A80C084AD

Q34075430-7F6A131D-9831-4D75-BF2A-AA31C509932C

P304

Q34075430-13B8BB33-CB42-4497-92A3-937AB46D16BE

P31

Q34075430-33DD4CCA-D876-4310-9D49-EF073170D4C5

P356

Q34075430-D3C60F59-C04A-4FDC-B6E0-223E5FF6F334

P433

Q34075430-7234198B-4B6A-4195-8A1E-83D0E8AC1024

P478

Q34075430-87FE6EA1-9947-436C-9A10-931910408106

P50

Q34075430-7E49E8E9-0DB5-424E-B1C4-01204D9AEBEC

P577

Q34075430-4E2A0381-AAFB-4F11-BA2A-8FF8143ED8F1

P698

Q34075430-63F8C1B6-BD65-4C83-ACBC-8975ECC20880

P921

Q34075430-4C398F4C-225E-4299-AAA4-C6E0E1F6178C

P932

Q34075430-A3520D5A-27EC-4814-86DD-AC5B3192EBC7

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Obesity-related glomerulopathy: body mass index and proteinuria.

@en

P2093

Feng Xu

http://www.w3.org/2001/XMLSchema#string

Hao Chen

http://www.w3.org/2001/XMLSchema#string

Hui-mei Chen

http://www.w3.org/2001/XMLSchema#string

Lei-shi Li

http://www.w3.org/2001/XMLSchema#string

Wen-wen Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults

A review and meta-analysis of the effect of weight loss on all-cause mortality risk

Obesity-related glomerulopathy: an emerging epidemic.

Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis

Effect of onsite dietitian counseling on weight loss and lipid levels in an outpatient physician office

Laparoscopic sleeve gastrectomy: a retrospective review of 1- and 2-year results.

Decreased body mass index as an independent risk factor for developing chronic kidney disease.

Rhein reverses the diabetic phenotype of mesangial cells over-expressing the glucose transporter (GLUT1) by inhibiting the hexosamine pathway.

Prevalence of prehypertension and hypertension in a Chinese rural area from 1991 to 2007.

Additive antiproteinuric effect of combined ACE inhibition and angiotensin II receptor blockade.

P304

1401-1409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.01370210

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20498244

http://www.w3.org/2001/XMLSchema#string

P921

P932

2924407

http://www.w3.org/2001/XMLSchema#string